Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor–Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202

PURPOSE: Adherence to aromatase inhibitor (AI) therapy for early-stage breast cancer is limited by AI-associated musculoskeletal symptoms (AIMSS). Duloxetine is US Food and Drug Administration approved for treatment of multiple chronic pain disorders. We hypothesized that treatment of AIMSS with dul...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Clin Oncol
Glavni autori: Henry, N. Lynn, Unger, Joseph M., Schott, Anne F., Fehrenbacher, Louis, Flynn, Patrick J., Prow, Debra M., Sharer, Carl W., Burton, Gary V., Kuzma, Charles S., Moseley, Anna, Lew, Danika L., Fisch, Michael J., Moinpour, Carol M., Hershman, Dawn L., Wade, James L.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Clinical Oncology 2018
Teme:
ORIGINAL REPORTS
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5805479/
https://ncbi.nlm.nih.gov/pubmed/29136387
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2017.74.6651
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items